It became clear that dementia progresses very differently, both between and within
individuals. This implies an average trajectory is not informative to individual persons and …

Despite being the second most common form of neurodegenerative dementia, dementia
with Lewy bodies (DLB) is under-recognized and carries a worse prognosis than other …

Background and Objectives Neuroinflammation contributes to Parkinson disease (PD)
pathology, and inflammatory biomarkers may aid in PD diagnosis. Proximity extension assay …

Objective The objective of this study was to examine clinical characteristics, cognitive
decline, and predictors for time to dementia in prodromal dementia with Lewy bodies with …

Objective: The present study aimed to clarify the neuropsychological profile of the emergent
diagnostic category of Mild Cognitive Impairment with Lewy bodies (MCI-LB) and determine …

This spreading of prion proteins is at the basis of brain neurodegeneration. This paper deals
with the numerical modelling of the misfolding process of α-synuclein in Parkinson's …

Background and Objectives Evaluating and understanding the heterogeneity in dementia
course has important implications for clinical practice, health care decision-making, and …

Objective This study aimed to quantify the trajectory and magnitude of change of the key
clinical features and corresponding symptom domains of dementia with Lewy bodies (DLB) …

Abstract Background The Trail Making Test (TMT) Part A (TMT-A) is a good measure of
performance on cognitive processing speed. This study aimed to perform a genome-wide …

Introduction This study assessed the construct validity and clinical utility of the National
Alzheimer's Coordinating Center Lewy Body Dementia (LBD) Module, consisting of the …